TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 17, No. 24 December 15, 2011
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
ANNOUNCEMENTS
Our best holiday wishes to all the TRIGGER subscribers for a happy, healthy and prosperous New Year!
-Jim & Genie Morrissey and Pierre Neuenschwander
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
UPCOMING MEETINGS & EVENTS
The meeting brochure and online registration for the upcoming "6th Symposium on Hemostasis with Special Focus on Tissue Factor, Factor VIIa and Tissue Factor Pathway Inhibitor-- Hemostasis and Beyond" are now available at:
http://medicine.med.unc.edu/hemonc/tf2012
The meeting will be held on 3-5 May 2012, at the Carolina Inn, Chapel Hill NC, USA.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 17, No. 24 December 15, 2011
(The next issue will be on January 2, 2012)
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
ANNOUNCEMENTS
Our best holiday wishes to all the TRIGGER subscribers for a happy, healthy and prosperous New Year!
-Jim & Genie Morrissey and Pierre Neuenschwander
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
UPCOMING MEETINGS & EVENTS
The meeting brochure and online registration for the upcoming "6th Symposium on Hemostasis with Special Focus on Tissue Factor, Factor VIIa and Tissue Factor Pathway Inhibitor-- Hemostasis and Beyond" are now available at:
http://medicine.med.unc.edu/hemonc/tf2012
The meeting will be held on 3-5 May 2012, at the Carolina Inn, Chapel Hill NC, USA.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1jme8kBYm8u5kkri2b58UN-/
Binny C, McIntosh J, Della Peruta M, Kymalainen H, Tuddenham EG, Buckley SM, . . . Nathwani AC (2011) AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous haemorrhage. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/22134170
Brophy DF, Martin EJ, Barrett JC, Nolte ME, Kuhn JG, Hedner U, Ezban M (2011) Overcoming delayed in-vitro response to rFVIIa: effects of rFVIIa and rFVIIa analogue (vatreptacog alfa) concentration escalation in whole blood assays. Blood Coagul Fibrinolysis 22:541-546.
http://www.ncbi.nlm.nih.gov/pubmed/21681082
Brophy DF, Martin EJ, Christian Barrett J, Nolte ME, Kuhn JG, Gerk PM, . . . Hedner U (2011) Monitoring rFVIIa 90 mug kg(1) dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 h. Haemophilia 17:e949-957.
http://www.ncbi.nlm.nih.gov/pubmed/21362113
Camire RM (2011) A new look at blood coagulation factor V. Curr Opin Hematol 18:338-342.
http://www.ncbi.nlm.nih.gov/pubmed/21730834
Carlsson K, Persson E, Lindgren M, Carlsson U, Svensson M (2011) Effects on the conformation of FVIIa by sTF and Ca(2) binding: studies of fluorescence resonance energy transfer and quenching. Biochem Biophys Res Commun 413:545-549.
http://www.ncbi.nlm.nih.gov/pubmed/21924243
Chavez-Tapia NC, Alfaro-Lara R, Tellez-Avila F, Barrientos-Gutierrez T, Gonzalez-Chon O, Mendez-Sanchez N, Uribe M (2011) Prophylactic activated recombinant factor VII in liver resection and liver transplantation: systematic review and meta-analysis. PLoS One 6:e22581.
http://www.ncbi.nlm.nih.gov/pubmed/21818342
Cocco E, Varughese J, Buza N, Bellone S, Lin KY, Bellone M, . . . Santin AD (2011) Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor. Clin Exp Metastasis 28:689-700.
http://www.ncbi.nlm.nih.gov/pubmed/21725665
Collins PW (2011) Management of acquired haemophilia A. J Thromb Haemost 9 Suppl 1:226-235.
http://www.ncbi.nlm.nih.gov/pubmed/21781259
Cui MZ (2011) Lysophosphatidic acid effects on atherosclerosis and thrombosis. Clin Lipidol 6:413-426.
http://www.ncbi.nlm.nih.gov/pubmed/22162980
Egorina EM, Sovershaev MA, Hansen JB (2011) The role of tissue factor in systemic inflammatory response syndrome. Blood Coagul Fibrinolysis 22:451-456.
http://www.ncbi.nlm.nih.gov/pubmed/21597365
Esmon CT, Xu J, Lupu F (2011) Innate immunity and coagulation. J Thromb Haemost 9 Suppl 1:182-188.
http://www.ncbi.nlm.nih.gov/pubmed/21781254
Girard TJ, Tuley E, Broze GJ, Jr. (2011) TFPIbeta is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/22144186
Gurusamy KS, Pissanou T, Pikhart H, Vaughan J, Burroughs AK, Davidson BR (2011) Methods to decrease blood loss and transfusion requirements for liver transplantation. Cochrane Database Syst Rev 12:CD009052.
http://www.ncbi.nlm.nih.gov/pubmed/22161443
Hay JW, Zhou ZY (2011) Economical comparison of APCC vs. rFVIIa for mild-to-moderate bleeding episodes in haemophilia patients with inhibitors. Haemophilia 17:e969-974.
http://www.ncbi.nlm.nih.gov/pubmed/21649802
Hibi K, Goto T, Shirahata A, Saito M, Kigawa G, Nemoto H, Sanada Y (2011) Detection of TFPI2 methylation in the serum of colorectal cancer patients. Cancer Lett 311:96-100.
http://www.ncbi.nlm.nih.gov/pubmed/21820798
Hoshi A, Matsumoto A, Chung J, Isozumi Y, Koyama T (2011) Activation of coagulation by a thalidomide-based regimen. Blood Coagul Fibrinolysis 22:532-540.
http://www.ncbi.nlm.nih.gov/pubmed/21670663
Hwang SM, Kim JE, Han KS, Kim HK (2011) Thrombomodulin phenotype of a distinct monocyte subtype is an independent prognostic marker for disseminated intravascular coagulation. Crit Care 15:R113.
http://www.ncbi.nlm.nih.gov/pubmed/21489300
Ingerslev J, Sorensen B (2011) Parallel use of by-passing agents in haemophilia with inhibitors: a critical review. Br J Haematol 155:256-262.
http://www.ncbi.nlm.nih.gov/pubmed/21895627
Kakko T, Jaakkola U, Raitakari OT, Kallio J (2011) Inflammatory effects of blood leukocytes: association with vascular function in neuropeptide Y proline 7-genotyped type 2 diabetes patients. Diab Vasc Dis Res 8:221-228.
http://www.ncbi.nlm.nih.gov/pubmed/21746772
Kayem G, Kurinczuk JJ, Alfirevic Z, Spark P, Brocklehurst P, Knight M (2011) Specific second-line therapies for postpartum haemorrhage: a national cohort study. BJOG 118:856-864.
http://www.ncbi.nlm.nih.gov/pubmed/21392247
Kim WJ, Oh JY, Son HJ, Chin JH, Choi DK, Lee EH, . . . Choi IC (2011) The prophylactic use of recombinant factor VIIa in a patient with DeBakey type III aortic dissection -A case report. Korean J Anesthesiol 61:431-434.
http://www.ncbi.nlm.nih.gov/pubmed/22148094
Knudsen T, Kjalke M, Tranholm M, Nichols TC, Jensen AL, Kristensen AT (2011) Development of a flow cytometric assay for detection of coated platelets in dogs and evaluation of binding of coated platelets to recombinant human coagulation factor VIIa. Am J Vet Res 72:1007-1014.
http://www.ncbi.nlm.nih.gov/pubmed/21801056
Kobayashi T, Nakabayashi M, Yoshioka A, Maeda M, Ikenoue T (2011) Recombinant activated factor VII (rFVIIa/NovoSeven((R))) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. Int J Hematol.
http://www.ncbi.nlm.nih.gov/pubmed/22160834
Krijnen PA, Hahn NE, Kholova I, Baylan U, Sipkens JA, van Alphen FP, . . . Niessen HW (2012) Loss of DPP4 activity is related to a prothrombogenic status of endothelial cells: implications for the coronary microvasculature of myocardial infarction patients. Basic Res Cardiol 107:1-13.
http://www.ncbi.nlm.nih.gov/pubmed/22167343
Kruthika-Vinod TP, Nagaraja D, Christopher R (2011) Coagulation factor VII R353Q polymorphism and the risk of puerperal cerebral venous thrombosis. J Clin Neurosci.
http://www.ncbi.nlm.nih.gov/pubmed/22136731
Krysiak R, Gdula-Dymek A, Okopien B (2011) Hemostatic effects of bezafibrate and omega-3 fatty acids in isolated hypertriglyceridemic patients. Pharmacol Rep 63:763-771.
http://www.ncbi.nlm.nih.gov/pubmed/21857087
Latchamsetty R, Gautam S, Bhakta D, Chugh A, John RM, Epstein LM, . . . Jongnarangsin K (2011) Management and outcomes of cardiac tamponade during atrial fibrillation ablation in the presence of therapeutic anticoagulation with warfarin. Heart Rhythm 8:805-808.
http://www.ncbi.nlm.nih.gov/pubmed/21236362
Lemon SJ, Jr., Crannage AJ (2011) Pharmacologic anticoagulation reversal in the emergency department. Adv Emerg Nurs J 33:212-223; quiz 224-215.
http://www.ncbi.nlm.nih.gov/pubmed/21836448
Li J, Liu Y, Yin W, Zhang C, Huang J, Liao C, . . . Xiao P (2011) Alterations of the preoperative coagulation profile in patients with acute appendicitis. Clin Chem Lab Med 49:1333-1339.
http://www.ncbi.nlm.nih.gov/pubmed/21663567
Lisman T, Porte RJ (2011) Recombinant factor VIIa to treat severe bleeding in patients with liver disease: pitfalls and possibilities. J Hepatol 55:950-951.
http://www.ncbi.nlm.nih.gov/pubmed/21925325
Liu Y, Jiang P, Capkova K, Xue D, Ye L, Sinha SC, . . . Liu C (2011) Tissue factor-activated coagulation cascade in the tumor microenvironment is critical for tumor progression and an effective target for therapy. Cancer Res 71:6492-6502.
http://www.ncbi.nlm.nih.gov/pubmed/21880589
Luszczak J, Undas A, Gissel M, Olszowska M, Butenas S (2011) Activated factor XI and tissue factor in aortic stenosis: links with thrombin generation. Blood Coagul Fibrinolysis 22:473-479.
http://www.ncbi.nlm.nih.gov/pubmed/21519234
Mayne E, Funderburg NT, Sieg SF, Asaad R, Kalinowska M, Rodriguez B, . . . Lederman MM (2011) Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expression. J Acquir Immune Defic Syndr.
http://www.ncbi.nlm.nih.gov/pubmed/22156911
Meisel SR, Xu XP, Edgington TS, Cercek B, Ong J, Kaul S, Shah PK (2011) Dose-dependent modulation of tissue factor protein and procoagulant activity in human monocyte-derived macrophages by oxidized low density lipoprotein. J Atheroscler Thromb 18:596-603.
http://www.ncbi.nlm.nih.gov/pubmed/21467727
Milligan C, Higginson I, Smith JE (2011) Emergency department staff knowledge of massive transfusion for trauma: the need for an evidence based protocol. Emerg Med J 28:870-872.
http://www.ncbi.nlm.nih.gov/pubmed/21030544
Paluszkiewicz P, Mayzner-Zawadzka E, Baranowski W, Breborowicz GH, Brzezinski M, Durek G, . . . Wujtewicz M (2011) Recommendations for the management of trauma or surgery-related massive blood loss. Pol Przegl Chir 83:465-476.
http://www.ncbi.nlm.nih.gov/pubmed/22166722
Park JB, Kim BK, Kwon YW, Muller DN, Lee HC, Youn SW, . . . Kim HS (2011) Peroxisome proliferator-activated receptor-gamma agonists suppress tissue factor overexpression in rat balloon injury model with Paclitaxel infusion. PLoS One 6:e28327.
http://www.ncbi.nlm.nih.gov/pubmed/22140576
Patanwala AE, Acquisto NM, Erstad BL (2011) Prothrombin complex concentrate for critical bleeding. Ann Pharmacother 45:990-999.
http://www.ncbi.nlm.nih.gov/pubmed/21730276
Peled E, Rovitsky A, Axelman E, Norman D, Brenner B, Nadir Y (2011) Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparin. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22154361
Quezada M, Diaz J, Henriquez S, Bravo ML, Aranda E, Oliva B, . . . Owen GI (2010) 2-Methoxyestradiol inhibits progesterone-dependent tissue factor expression and activity in breast cancer cells. Horm Cancer 1:117-126.
http://www.ncbi.nlm.nih.gov/pubmed/21761355
Rasekh HR, Imani A, Karimi M, Golestani M (2011) Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in Iran. Clinicoecon Outcomes Res 3:207-212.
http://www.ncbi.nlm.nih.gov/pubmed/22163168
Ruf W, Disse J, Carneiro-Lobo TC, Yokota N, Schaffner F (2011) Tissue factor and cell signalling in cancer progression and thrombosis. J Thromb Haemost 9 Suppl 1:306-315.
http://www.ncbi.nlm.nih.gov/pubmed/21781267
Saito Y, Hashimoto Y, Kuroda J, Yasunaga M, Koga Y, Takahashi A, Matsumura Y (2011) The inhibition of pancreatic cancer invasion-metastasis cascade in both cellular signal and blood coagulation cascade of tissue factor by its neutralisation antibody. Eur J Cancer 47:2230-2239.
http://www.ncbi.nlm.nih.gov/pubmed/21621407
Sangha N, Gonzales NR (2011) Treatment targets in intracerebral hemorrhage. Neurotherapeutics 8:374-387.
http://www.ncbi.nlm.nih.gov/pubmed/21732225
Sartori MT, Della Puppa A, Ballin A, Saggiorato G, Bernardi D, Padoan A, . . . Cella G (2011) Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles. J Neurooncol 104:225-231.
http://www.ncbi.nlm.nih.gov/pubmed/21104297
Schmid D, Svoboda M, Sorgner A, Moravcevic I, Thalhammer T, Chiba P, Moslinger T (2011) Glibenclamide reduces proinflammatory cytokines in an ex vivo model of human endotoxinaemia under hypoxaemic conditions. Life Sci 89:725-734.
http://www.ncbi.nlm.nih.gov/pubmed/21925514
Schmid P, Mordasini A, Luginbuhl M, Regli B, Kohler HP, Zimmermann H, . . . Alberio L (2011) Low-dose recombinant factor VIIa for massive bleeding: a single centre observational cohort study with 73 patients. Swiss Med Wkly 141:w13213.
http://www.ncbi.nlm.nih.gov/pubmed/21735365
Shander A, Walsh CE, Cromwell C (2011) Acquired hemophilia: a rare but life-threatening potential cause of bleeding in the intensive care unit. Intensive Care Med 37:1240-1249.
http://www.ncbi.nlm.nih.gov/pubmed/21626430
Siddiq S, Clark A, Mumford A (2011) A systematic review of the management and outcomes of pregnancy in Glanzmann thrombasthenia. Haemophilia 17:e858-869.
http://www.ncbi.nlm.nih.gov/pubmed/21457404
Sie P, Samama CM, Godier A, Rosencher N, Steib A, Llau JV, . . . Albaladejo P (2011) Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on perioperative haemostasis and the French Study Group on thrombosis and haemostasis. Arch Cardiovasc Dis 104:669-676.
http://www.ncbi.nlm.nih.gov/pubmed/22152517
Sorour Y, Van Veen JJ, Makris M (2010) Recombinant factor VIIa for unlicensed indications--a definite No or a cautious Maybe in selected patients? Int J Clin Pract 64:1468-1471.
http://www.ncbi.nlm.nih.gov/pubmed/20722768
Stephan F, Hazelzet JA, Bulder I, Boermeester MA, van Till JO, van der Poll T, . . . Zeerleder S (2011) Activation of factor VII-activating protease in human inflammation: a sensor for cell death. Crit Care 15:R110.
http://www.ncbi.nlm.nih.gov/pubmed/21466697
Stokol T, Daddona JL, Mubayed LS, Trimpert J, Kang S (2011) Evaluation of tissue factor expression in canine tumor cells. Am J Vet Res 72:1097-1106.
http://www.ncbi.nlm.nih.gov/pubmed/21801068
Storgaard M, Henriksen ST, Zaragoza F, Peschke B, Tanner D (2011) Design, synthesis and biological activity of novel peptidyl benzyl ketone FVIIa inhibitors. Bioorg Med Chem Lett 21:3918-3922.
http://www.ncbi.nlm.nih.gov/pubmed/21641796
Takeuchi H, Fernandez-Valdivia RC, Caswell DS, Nita-Lazar A, Rana NA, Garner TP, . . . Haltiwanger RS (2011) Rumi functions as both a protein O-glucosyltransferase and a protein O-xylosyltransferase. Proc Natl Acad Sci U S A 108:16600-16605.
http://www.ncbi.nlm.nih.gov/pubmed/21949356
Tang JQ, Fan Q, Wu WH, Jia ZC, Li H, Yang YM, . . . Wan YL (2010) Extrahepatic synthesis of coagulation factor VII by colorectal cancer cells promotes tumor invasion and metastasis. Chin Med J (Engl) 123:3559-3565.
http://www.ncbi.nlm.nih.gov/pubmed/22166631
Tran HT, Tjonnfjord GE, Paus A, Holme PA (2011) rFVIIa administered by continuous infusion during surgery in patients with severe congenital FVII deficiency. Haemophilia 17:764-770.
http://www.ncbi.nlm.nih.gov/pubmed/21707871
van den Hengel LG, Kocaturk B, Reitsma PH, Ruf W, Versteeg HH (2011) Complete abolishment of coagulant activity in monomeric disulfide-deficient tissue factor. Blood 118:3446-3448.
http://www.ncbi.nlm.nih.gov/pubmed/21940832
Vang ML, Hvas AM, Ravn HB (2011) Urgent reversal of vitamin K antagonist therapy. Acta Anaesthesiol Scand 55:507-516.
http://www.ncbi.nlm.nih.gov/pubmed/21418150
Versteeg HH, Ruf W (2011) Thiol pathways in the regulation of tissue factor prothrombotic activity. Curr Opin Hematol 18:343-348.
http://www.ncbi.nlm.nih.gov/pubmed/21778880
Walsh M, Thomas SG, Howard JC, Evans E, Guyer K, Medvecz A, . . . Castellino FJ (2011) Blood component therapy in trauma guided with the utilization of the perfusionist and thromboelastography. J Extra Corpor Technol 43:162-167.
http://www.ncbi.nlm.nih.gov/pubmed/22164456
Weatherall J, Barnes N, Brown C, Preaud E (2011) Future characteristics of bypassing agents to improve care of hemophilia inhibitor patients: an economic and health-related quality of life perspective. Expert Rev Pharmacoecon Outcomes Res 11:411-414.
http://www.ncbi.nlm.nih.gov/pubmed/21831021
Wyckoff T, Reed EA, Desai ND, Augoustides JG (2011) Possible Anaphylaxis Due to Recombinant Factor VIIa Administration During Thoracic Aortic Surgery. J Cardiothorac Vasc Anesth.
http://www.ncbi.nlm.nih.gov/pubmed/22155168
Yamamoto E, Nishimura N, Okada K, Sekido C, Yamamichi S, Hasumi K (2011) Inhibitors of autoactivation of plasma hyaluronan-binding protein (factor VII activating protease). Biol Pharm Bull 34:462-470.
http://www.ncbi.nlm.nih.gov/pubmed/21467630
Young G, Auerswald G, Jimenez-Yuste V, Konkle BA, Lambert T, Morfini M, . . . Blanchette V (2011) When should prophylaxis therapy in inhibitor patients be considered? Haemophilia 17:e849-857.
http://www.ncbi.nlm.nih.gov/pubmed/21418444
Zhu J, Xie R, Piao X, Hou Y, Zhao C, Qiao G, . . . Lu Y (2011) Homocysteine enhances clot-promoting activity of endothelial cells via phosphatidylserine externalization and microparticles formation. Amino Acids.
http://www.ncbi.nlm.nih.gov/pubmed/22160264
__________________________________________________________
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1jme8kBYm8u5kkri2b58UN-/
Binny C, McIntosh J, Della Peruta M, Kymalainen H, Tuddenham EG, Buckley SM, . . . Nathwani AC (2011) AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous haemorrhage. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/22134170
Brophy DF, Martin EJ, Barrett JC, Nolte ME, Kuhn JG, Hedner U, Ezban M (2011) Overcoming delayed in-vitro response to rFVIIa: effects of rFVIIa and rFVIIa analogue (vatreptacog alfa) concentration escalation in whole blood assays. Blood Coagul Fibrinolysis 22:541-546.
http://www.ncbi.nlm.nih.gov/pubmed/21681082
Brophy DF, Martin EJ, Christian Barrett J, Nolte ME, Kuhn JG, Gerk PM, . . . Hedner U (2011) Monitoring rFVIIa 90 mug kg(1) dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 h. Haemophilia 17:e949-957.
http://www.ncbi.nlm.nih.gov/pubmed/21362113
Camire RM (2011) A new look at blood coagulation factor V. Curr Opin Hematol 18:338-342.
http://www.ncbi.nlm.nih.gov/pubmed/21730834
Carlsson K, Persson E, Lindgren M, Carlsson U, Svensson M (2011) Effects on the conformation of FVIIa by sTF and Ca(2) binding: studies of fluorescence resonance energy transfer and quenching. Biochem Biophys Res Commun 413:545-549.
http://www.ncbi.nlm.nih.gov/pubmed/21924243
Chavez-Tapia NC, Alfaro-Lara R, Tellez-Avila F, Barrientos-Gutierrez T, Gonzalez-Chon O, Mendez-Sanchez N, Uribe M (2011) Prophylactic activated recombinant factor VII in liver resection and liver transplantation: systematic review and meta-analysis. PLoS One 6:e22581.
http://www.ncbi.nlm.nih.gov/pubmed/21818342
Cocco E, Varughese J, Buza N, Bellone S, Lin KY, Bellone M, . . . Santin AD (2011) Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor. Clin Exp Metastasis 28:689-700.
http://www.ncbi.nlm.nih.gov/pubmed/21725665
Collins PW (2011) Management of acquired haemophilia A. J Thromb Haemost 9 Suppl 1:226-235.
http://www.ncbi.nlm.nih.gov/pubmed/21781259
Cui MZ (2011) Lysophosphatidic acid effects on atherosclerosis and thrombosis. Clin Lipidol 6:413-426.
http://www.ncbi.nlm.nih.gov/pubmed/22162980
Egorina EM, Sovershaev MA, Hansen JB (2011) The role of tissue factor in systemic inflammatory response syndrome. Blood Coagul Fibrinolysis 22:451-456.
http://www.ncbi.nlm.nih.gov/pubmed/21597365
Esmon CT, Xu J, Lupu F (2011) Innate immunity and coagulation. J Thromb Haemost 9 Suppl 1:182-188.
http://www.ncbi.nlm.nih.gov/pubmed/21781254
Girard TJ, Tuley E, Broze GJ, Jr. (2011) TFPIbeta is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/22144186
Gurusamy KS, Pissanou T, Pikhart H, Vaughan J, Burroughs AK, Davidson BR (2011) Methods to decrease blood loss and transfusion requirements for liver transplantation. Cochrane Database Syst Rev 12:CD009052.
http://www.ncbi.nlm.nih.gov/pubmed/22161443
Hay JW, Zhou ZY (2011) Economical comparison of APCC vs. rFVIIa for mild-to-moderate bleeding episodes in haemophilia patients with inhibitors. Haemophilia 17:e969-974.
http://www.ncbi.nlm.nih.gov/pubmed/21649802
Hibi K, Goto T, Shirahata A, Saito M, Kigawa G, Nemoto H, Sanada Y (2011) Detection of TFPI2 methylation in the serum of colorectal cancer patients. Cancer Lett 311:96-100.
http://www.ncbi.nlm.nih.gov/pubmed/21820798
Hoshi A, Matsumoto A, Chung J, Isozumi Y, Koyama T (2011) Activation of coagulation by a thalidomide-based regimen. Blood Coagul Fibrinolysis 22:532-540.
http://www.ncbi.nlm.nih.gov/pubmed/21670663
Hwang SM, Kim JE, Han KS, Kim HK (2011) Thrombomodulin phenotype of a distinct monocyte subtype is an independent prognostic marker for disseminated intravascular coagulation. Crit Care 15:R113.
http://www.ncbi.nlm.nih.gov/pubmed/21489300
Ingerslev J, Sorensen B (2011) Parallel use of by-passing agents in haemophilia with inhibitors: a critical review. Br J Haematol 155:256-262.
http://www.ncbi.nlm.nih.gov/pubmed/21895627
Kakko T, Jaakkola U, Raitakari OT, Kallio J (2011) Inflammatory effects of blood leukocytes: association with vascular function in neuropeptide Y proline 7-genotyped type 2 diabetes patients. Diab Vasc Dis Res 8:221-228.
http://www.ncbi.nlm.nih.gov/pubmed/21746772
Kayem G, Kurinczuk JJ, Alfirevic Z, Spark P, Brocklehurst P, Knight M (2011) Specific second-line therapies for postpartum haemorrhage: a national cohort study. BJOG 118:856-864.
http://www.ncbi.nlm.nih.gov/pubmed/21392247
Kim WJ, Oh JY, Son HJ, Chin JH, Choi DK, Lee EH, . . . Choi IC (2011) The prophylactic use of recombinant factor VIIa in a patient with DeBakey type III aortic dissection -A case report. Korean J Anesthesiol 61:431-434.
http://www.ncbi.nlm.nih.gov/pubmed/22148094
Knudsen T, Kjalke M, Tranholm M, Nichols TC, Jensen AL, Kristensen AT (2011) Development of a flow cytometric assay for detection of coated platelets in dogs and evaluation of binding of coated platelets to recombinant human coagulation factor VIIa. Am J Vet Res 72:1007-1014.
http://www.ncbi.nlm.nih.gov/pubmed/21801056
Kobayashi T, Nakabayashi M, Yoshioka A, Maeda M, Ikenoue T (2011) Recombinant activated factor VII (rFVIIa/NovoSeven((R))) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. Int J Hematol.
http://www.ncbi.nlm.nih.gov/pubmed/22160834
Krijnen PA, Hahn NE, Kholova I, Baylan U, Sipkens JA, van Alphen FP, . . . Niessen HW (2012) Loss of DPP4 activity is related to a prothrombogenic status of endothelial cells: implications for the coronary microvasculature of myocardial infarction patients. Basic Res Cardiol 107:1-13.
http://www.ncbi.nlm.nih.gov/pubmed/22167343
Kruthika-Vinod TP, Nagaraja D, Christopher R (2011) Coagulation factor VII R353Q polymorphism and the risk of puerperal cerebral venous thrombosis. J Clin Neurosci.
http://www.ncbi.nlm.nih.gov/pubmed/22136731
Krysiak R, Gdula-Dymek A, Okopien B (2011) Hemostatic effects of bezafibrate and omega-3 fatty acids in isolated hypertriglyceridemic patients. Pharmacol Rep 63:763-771.
http://www.ncbi.nlm.nih.gov/pubmed/21857087
Latchamsetty R, Gautam S, Bhakta D, Chugh A, John RM, Epstein LM, . . . Jongnarangsin K (2011) Management and outcomes of cardiac tamponade during atrial fibrillation ablation in the presence of therapeutic anticoagulation with warfarin. Heart Rhythm 8:805-808.
http://www.ncbi.nlm.nih.gov/pubmed/21236362
Lemon SJ, Jr., Crannage AJ (2011) Pharmacologic anticoagulation reversal in the emergency department. Adv Emerg Nurs J 33:212-223; quiz 224-215.
http://www.ncbi.nlm.nih.gov/pubmed/21836448
Li J, Liu Y, Yin W, Zhang C, Huang J, Liao C, . . . Xiao P (2011) Alterations of the preoperative coagulation profile in patients with acute appendicitis. Clin Chem Lab Med 49:1333-1339.
http://www.ncbi.nlm.nih.gov/pubmed/21663567
Lisman T, Porte RJ (2011) Recombinant factor VIIa to treat severe bleeding in patients with liver disease: pitfalls and possibilities. J Hepatol 55:950-951.
http://www.ncbi.nlm.nih.gov/pubmed/21925325
Liu Y, Jiang P, Capkova K, Xue D, Ye L, Sinha SC, . . . Liu C (2011) Tissue factor-activated coagulation cascade in the tumor microenvironment is critical for tumor progression and an effective target for therapy. Cancer Res 71:6492-6502.
http://www.ncbi.nlm.nih.gov/pubmed/21880589
Luszczak J, Undas A, Gissel M, Olszowska M, Butenas S (2011) Activated factor XI and tissue factor in aortic stenosis: links with thrombin generation. Blood Coagul Fibrinolysis 22:473-479.
http://www.ncbi.nlm.nih.gov/pubmed/21519234
Mayne E, Funderburg NT, Sieg SF, Asaad R, Kalinowska M, Rodriguez B, . . . Lederman MM (2011) Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expression. J Acquir Immune Defic Syndr.
http://www.ncbi.nlm.nih.gov/pubmed/22156911
Meisel SR, Xu XP, Edgington TS, Cercek B, Ong J, Kaul S, Shah PK (2011) Dose-dependent modulation of tissue factor protein and procoagulant activity in human monocyte-derived macrophages by oxidized low density lipoprotein. J Atheroscler Thromb 18:596-603.
http://www.ncbi.nlm.nih.gov/pubmed/21467727
Milligan C, Higginson I, Smith JE (2011) Emergency department staff knowledge of massive transfusion for trauma: the need for an evidence based protocol. Emerg Med J 28:870-872.
http://www.ncbi.nlm.nih.gov/pubmed/21030544
Paluszkiewicz P, Mayzner-Zawadzka E, Baranowski W, Breborowicz GH, Brzezinski M, Durek G, . . . Wujtewicz M (2011) Recommendations for the management of trauma or surgery-related massive blood loss. Pol Przegl Chir 83:465-476.
http://www.ncbi.nlm.nih.gov/pubmed/22166722
Park JB, Kim BK, Kwon YW, Muller DN, Lee HC, Youn SW, . . . Kim HS (2011) Peroxisome proliferator-activated receptor-gamma agonists suppress tissue factor overexpression in rat balloon injury model with Paclitaxel infusion. PLoS One 6:e28327.
http://www.ncbi.nlm.nih.gov/pubmed/22140576
Patanwala AE, Acquisto NM, Erstad BL (2011) Prothrombin complex concentrate for critical bleeding. Ann Pharmacother 45:990-999.
http://www.ncbi.nlm.nih.gov/pubmed/21730276
Peled E, Rovitsky A, Axelman E, Norman D, Brenner B, Nadir Y (2011) Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparin. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22154361
Quezada M, Diaz J, Henriquez S, Bravo ML, Aranda E, Oliva B, . . . Owen GI (2010) 2-Methoxyestradiol inhibits progesterone-dependent tissue factor expression and activity in breast cancer cells. Horm Cancer 1:117-126.
http://www.ncbi.nlm.nih.gov/pubmed/21761355
Rasekh HR, Imani A, Karimi M, Golestani M (2011) Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in Iran. Clinicoecon Outcomes Res 3:207-212.
http://www.ncbi.nlm.nih.gov/pubmed/22163168
Ruf W, Disse J, Carneiro-Lobo TC, Yokota N, Schaffner F (2011) Tissue factor and cell signalling in cancer progression and thrombosis. J Thromb Haemost 9 Suppl 1:306-315.
http://www.ncbi.nlm.nih.gov/pubmed/21781267
Saito Y, Hashimoto Y, Kuroda J, Yasunaga M, Koga Y, Takahashi A, Matsumura Y (2011) The inhibition of pancreatic cancer invasion-metastasis cascade in both cellular signal and blood coagulation cascade of tissue factor by its neutralisation antibody. Eur J Cancer 47:2230-2239.
http://www.ncbi.nlm.nih.gov/pubmed/21621407
Sangha N, Gonzales NR (2011) Treatment targets in intracerebral hemorrhage. Neurotherapeutics 8:374-387.
http://www.ncbi.nlm.nih.gov/pubmed/21732225
Sartori MT, Della Puppa A, Ballin A, Saggiorato G, Bernardi D, Padoan A, . . . Cella G (2011) Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles. J Neurooncol 104:225-231.
http://www.ncbi.nlm.nih.gov/pubmed/21104297
Schmid D, Svoboda M, Sorgner A, Moravcevic I, Thalhammer T, Chiba P, Moslinger T (2011) Glibenclamide reduces proinflammatory cytokines in an ex vivo model of human endotoxinaemia under hypoxaemic conditions. Life Sci 89:725-734.
http://www.ncbi.nlm.nih.gov/pubmed/21925514
Schmid P, Mordasini A, Luginbuhl M, Regli B, Kohler HP, Zimmermann H, . . . Alberio L (2011) Low-dose recombinant factor VIIa for massive bleeding: a single centre observational cohort study with 73 patients. Swiss Med Wkly 141:w13213.
http://www.ncbi.nlm.nih.gov/pubmed/21735365
Shander A, Walsh CE, Cromwell C (2011) Acquired hemophilia: a rare but life-threatening potential cause of bleeding in the intensive care unit. Intensive Care Med 37:1240-1249.
http://www.ncbi.nlm.nih.gov/pubmed/21626430
Siddiq S, Clark A, Mumford A (2011) A systematic review of the management and outcomes of pregnancy in Glanzmann thrombasthenia. Haemophilia 17:e858-869.
http://www.ncbi.nlm.nih.gov/pubmed/21457404
Sie P, Samama CM, Godier A, Rosencher N, Steib A, Llau JV, . . . Albaladejo P (2011) Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on perioperative haemostasis and the French Study Group on thrombosis and haemostasis. Arch Cardiovasc Dis 104:669-676.
http://www.ncbi.nlm.nih.gov/pubmed/22152517
Sorour Y, Van Veen JJ, Makris M (2010) Recombinant factor VIIa for unlicensed indications--a definite No or a cautious Maybe in selected patients? Int J Clin Pract 64:1468-1471.
http://www.ncbi.nlm.nih.gov/pubmed/20722768
Stephan F, Hazelzet JA, Bulder I, Boermeester MA, van Till JO, van der Poll T, . . . Zeerleder S (2011) Activation of factor VII-activating protease in human inflammation: a sensor for cell death. Crit Care 15:R110.
http://www.ncbi.nlm.nih.gov/pubmed/21466697
Stokol T, Daddona JL, Mubayed LS, Trimpert J, Kang S (2011) Evaluation of tissue factor expression in canine tumor cells. Am J Vet Res 72:1097-1106.
http://www.ncbi.nlm.nih.gov/pubmed/21801068
Storgaard M, Henriksen ST, Zaragoza F, Peschke B, Tanner D (2011) Design, synthesis and biological activity of novel peptidyl benzyl ketone FVIIa inhibitors. Bioorg Med Chem Lett 21:3918-3922.
http://www.ncbi.nlm.nih.gov/pubmed/21641796
Takeuchi H, Fernandez-Valdivia RC, Caswell DS, Nita-Lazar A, Rana NA, Garner TP, . . . Haltiwanger RS (2011) Rumi functions as both a protein O-glucosyltransferase and a protein O-xylosyltransferase. Proc Natl Acad Sci U S A 108:16600-16605.
http://www.ncbi.nlm.nih.gov/pubmed/21949356
Tang JQ, Fan Q, Wu WH, Jia ZC, Li H, Yang YM, . . . Wan YL (2010) Extrahepatic synthesis of coagulation factor VII by colorectal cancer cells promotes tumor invasion and metastasis. Chin Med J (Engl) 123:3559-3565.
http://www.ncbi.nlm.nih.gov/pubmed/22166631
Tran HT, Tjonnfjord GE, Paus A, Holme PA (2011) rFVIIa administered by continuous infusion during surgery in patients with severe congenital FVII deficiency. Haemophilia 17:764-770.
http://www.ncbi.nlm.nih.gov/pubmed/21707871
van den Hengel LG, Kocaturk B, Reitsma PH, Ruf W, Versteeg HH (2011) Complete abolishment of coagulant activity in monomeric disulfide-deficient tissue factor. Blood 118:3446-3448.
http://www.ncbi.nlm.nih.gov/pubmed/21940832
Vang ML, Hvas AM, Ravn HB (2011) Urgent reversal of vitamin K antagonist therapy. Acta Anaesthesiol Scand 55:507-516.
http://www.ncbi.nlm.nih.gov/pubmed/21418150
Versteeg HH, Ruf W (2011) Thiol pathways in the regulation of tissue factor prothrombotic activity. Curr Opin Hematol 18:343-348.
http://www.ncbi.nlm.nih.gov/pubmed/21778880
Walsh M, Thomas SG, Howard JC, Evans E, Guyer K, Medvecz A, . . . Castellino FJ (2011) Blood component therapy in trauma guided with the utilization of the perfusionist and thromboelastography. J Extra Corpor Technol 43:162-167.
http://www.ncbi.nlm.nih.gov/pubmed/22164456
Weatherall J, Barnes N, Brown C, Preaud E (2011) Future characteristics of bypassing agents to improve care of hemophilia inhibitor patients: an economic and health-related quality of life perspective. Expert Rev Pharmacoecon Outcomes Res 11:411-414.
http://www.ncbi.nlm.nih.gov/pubmed/21831021
Wyckoff T, Reed EA, Desai ND, Augoustides JG (2011) Possible Anaphylaxis Due to Recombinant Factor VIIa Administration During Thoracic Aortic Surgery. J Cardiothorac Vasc Anesth.
http://www.ncbi.nlm.nih.gov/pubmed/22155168
Yamamoto E, Nishimura N, Okada K, Sekido C, Yamamichi S, Hasumi K (2011) Inhibitors of autoactivation of plasma hyaluronan-binding protein (factor VII activating protease). Biol Pharm Bull 34:462-470.
http://www.ncbi.nlm.nih.gov/pubmed/21467630
Young G, Auerswald G, Jimenez-Yuste V, Konkle BA, Lambert T, Morfini M, . . . Blanchette V (2011) When should prophylaxis therapy in inhibitor patients be considered? Haemophilia 17:e849-857.
http://www.ncbi.nlm.nih.gov/pubmed/21418444
Zhu J, Xie R, Piao X, Hou Y, Zhao C, Qiao G, . . . Lu Y (2011) Homocysteine enhances clot-promoting activity of endothelial cells via phosphatidylserine externalization and microparticles formation. Amino Acids.
http://www.ncbi.nlm.nih.gov/pubmed/22160264
__________________________________________________________
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
No comments:
Post a Comment